Journey Medical Corp Cost of Revenue
Journey Medical Corp (DERM) reported Cost of Revenue of $6.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2026-08-12
- Journey Medical Corp cost of revenue for the quarter ending 2026-06-30 was $6.14M, a 24.38% increase year-over-year.
- Journey Medical Corp cost of revenue for the quarter ending 2026-03-31 was $6.22M, a 29.81% increase year-over-year.
- Journey Medical Corp cost of revenue for the quarter ending 2025-06-30 was $4.94M, a 24.49% decline year-over-year.
- Journey Medical Corp cost of revenue for the quarter ending 2025-03-31 was $4.79M, a 29.72% decline year-over-year.
- Journey Medical Corp cost of revenue for fiscal 2025 was $20.92M, a 0.22% increase from fiscal 2024.
- Journey Medical Corp cost of revenue for fiscal 2024 was $20.88M, a 8.80% decline from fiscal 2023.
- Journey Medical Corp cost of revenue for fiscal 2023 was $22.89M, a 25.61% decline from fiscal 2022.
- Journey Medical Corp cost of revenue for fiscal 2022 was $30.77M, a 4.08% decline from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $6.14M 10-Q · filed 2026-08-12 | $12.36M 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | $6.22M 10-Q · filed 2026-05-13 | ||||
| 2025-12-31 | $20.92M 10-K · filed 2026-03-26 | ||||
| 2025-06-30 | $4.94M 10-Q · filed 2026-08-12 | $9.73M 10-Q · filed 2026-08-12 | $11.97M derived: sum of 3 quarters · filed 2026-08-12 | $17.25M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $4.79M 10-Q · filed 2026-05-13 | $7.03M derived: sum of 2 quarters · filed 2026-05-13 | $12.31M derived: sum of 3 quarters · filed 2026-05-13 | $18.85M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $7.52M derived: sum of 2 quarters · filed 2026-03-26 | $14.06M derived: sum of 3 quarters · filed 2026-03-26 | $20.88M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $5.29M 10-Q · filed 2024-11-12 | $11.83M derived: sum of 2 quarters · filed 2024-11-12 | $18.64M 10-Q · filed 2024-11-12 | $20.89M derived: sum of 4 quarters · filed 2025-03-27 | |
| 2024-06-30 | $6.54M 10-Q · filed 2024-08-13 | $13.36M 10-Q · filed 2024-08-13 | $15.61M derived: sum of 3 quarters · filed 2025-03-27 | $22.03M derived: sum of 4 quarters · filed 2025-03-27 | |
| 2024-03-31 | $6.82M 10-Q · filed 2024-05-14 | $9.06M derived: sum of 2 quarters · filed 2025-03-27 | $15.49M derived: sum of 3 quarters · filed 2025-03-27 | $23.26M derived: sum of 4 quarters · filed 2025-03-27 | |
| 2023-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $8.68M derived: sum of 2 quarters · filed 2025-03-27 | $16.44M derived: sum of 3 quarters · filed 2025-03-27 | $22.89M 10-K · filed 2025-03-27 | $26.66M 10-K · filed 2024-03-29 |
| 2023-09-30 | $6.43M 10-Q · filed 2024-11-12 | $14.20M derived: sum of 2 quarters · filed 2024-11-12 | $20.64M 10-Q · filed 2024-11-12 | $28.36M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $7.77M 10-Q · filed 2024-08-13 | $14.22M 10-Q · filed 2024-08-13 | $21.93M derived: sum of 3 quarters · filed 2024-08-13 | $29.16M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $6.45M 10-Q · filed 2024-05-14 | $14.17M derived: sum of 2 quarters · filed 2024-05-14 | $21.39M derived: sum of 3 quarters · filed 2024-05-14 | $29.02M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $7.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $14.94M derived: sum of 2 quarters · filed 2024-03-29 | $22.57M derived: sum of 3 quarters · filed 2024-03-29 | $30.77M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $7.22M 10-Q · filed 2023-11-13 | $14.85M derived: sum of 2 quarters · filed 2023-11-13 | $23.06M 10-Q · filed 2023-11-13 | $32.58M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $7.63M 10-Q · filed 2023-08-10 | $15.84M 10-Q · filed 2023-08-10 | $25.36M derived: sum of 3 quarters · filed 2023-08-10 | $36.53M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $8.20M 10-Q · filed 2023-05-22 | $17.73M derived: sum of 2 quarters · filed 2023-05-22 | $28.89M derived: sum of 3 quarters · filed 2023-05-22 | $36.38M derived: sum of 4 quarters · filed 2023-05-22 | |
| 2021-12-31 | $9.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $20.69M derived: sum of 2 quarters · filed 2023-03-31 | $28.18M derived: sum of 3 quarters · filed 2023-03-31 | $32.08M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $11.17M 10-Q · filed 2022-11-10 | $18.65M derived: sum of 2 quarters · filed 2022-11-10 | $22.56M 10-Q · filed 2022-11-10 | $26.84M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $7.48M 10-Q · filed 2022-08-09 | $11.39M 10-Q · filed 2022-08-09 | $15.67M derived: sum of 3 quarters · filed 2022-08-09 | $19.05M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | $3.91M 10-Q · filed 2022-05-10 | $8.19M derived: sum of 2 quarters · filed 2022-05-10 | $11.57M derived: sum of 3 quarters · filed 2022-05-10 | ||
| 2020-12-31 | $4.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $7.66M derived: sum of 2 quarters · filed 2022-03-28 | $14.59M 10-K · filed 2022-03-28 | ||
| 2020-09-30 | $3.38M 10-Q · filed 2021-12-16 | $10.31M 10-Q · filed 2021-12-16 |